There are 2789 resources available
157P - Moderate physical activity (MPA) modulates immune system in breast cancer (BC) patients during preoperative chemotherapy: The NEO-RUNNER study
Presenter: Ornella Garrone
Session: ePoster Display
158P - Prognosis of pregnancy after breast cancer diagnosis according to the treatment
Presenter: Sungmin Park
Session: ePoster Display
159P - SiMosein, a real-life prospective evaluation of EndoPredict use in early ER-positive, HER2-negative breast cancers
Presenter: Jacqueline Lehmann-Che
Session: ePoster Display
161P - Population effectiveness model of the consequences of recurrence after trastuzumab emtansine (T-DM1) treatment among U.S. patients with high-risk HER2+ early-stage breast cancer (ESBC)
Presenter: David Veenstra
Session: ePoster Display
162P - Prevalence and spectrum analysis of germline BRCA1 and BRCA2 variants of unclear significance in HBOC Syndrome: Decoding the mysterious signals of the genome
Presenter: Alessia Fiorino
Session: ePoster Display
163P - Is breast-conserving surgery safe in young African breast cancer patients?
Presenter: Abeid Athman Omar
Session: ePoster Display
164P - Effect of ELOVL5 expression on breast cancer development
Presenter: Trinh Le Vi Kieu
Session: ePoster Display
165P - Pathologic and immunohistochemical prognostic score in residual triple-negative breast cancer after neoadjuvant chemotherapy
Presenter: Silvia Mihaela Ilie
Session: ePoster Display
166P - Hereditary breast, ovarian and pancreatic cancers: Looking beyond the BRCA1/2 genes
Presenter: Marco Bono
Session: ePoster Display